Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors
Open Access
- 26 August 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 2 (6) , 1661-1668
Abstract
Mouse double minute 2 homolog (MDM2, Hdm2) is an important negative regulator of the tumor suppressor p53. Using a mRNA based display technique to screen a library of >1012in vitro-translated cyclic peptides, we have identified a macrocyclic ligand that shows picomolar potency on MDM2. X-Ray crystallography reveals a novel binding mode utilizing a unique pharmacophore to occupy the Phe/Trp/Leu pockets on MDM2. Conjugation of a cyclic cell-penetrating peptide (cCPP) to the initially non cell-permeable ligand enables cellular uptake and a pharmacodynamic response in SJSA-1 cells. The demonstrated enhanced intracellular availability of cyclic peptides that are identified by a display technology exemplifies a process for the application of intracellular tools for drug discovery projects.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SPP 1623 and RTG2473/ Projektnummer: 392923329)
- German-Israeli Foundation for Scientific Research and Development
This publication has 36 references indexed in Scilit:
- Towards understanding cell penetration by stapled peptidesMedChemComm, 2014
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapyProceedings of the National Academy of Sciences, 2013
- TRAP Display: A High-Speed Selection Method for the Generation of Functional PolypeptidesJournal of the American Chemical Society, 2013
- Stabilizing the Pro-Apoptotic BimBH3 Helix (BimSAHB) Does Not Necessarily Enhance Affinity or Biological ActivityACS Chemical Biology, 2012
- The p53 mRNA-Mdm2 Interaction Controls Mdm2 Nuclear Trafficking and Is Required for p53 Activation following DNA DamageCancer Cell, 2012
- Flexizymes for genetic code reprogrammingNature Protocols, 2011
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMXProceedings of the National Academy of Sciences, 2009
- A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating PeptidesTraffic, 2007
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996